The new commercial name of the COVID-19 VACCINE MODERNA is spikevax

The new commercial name of the COVID-19 VACCINE MODERNA is spikevax

In connection with a Mag's letter. FARM Bogdan Kirilov, Executive Director of the Medicines Executive Agency, we will notify you that a new trade name of [COVID-19 VACCINE MODERNA] (https://www.bda.bg/images/stories/documents/vaccinesLy- COVID-19-VACCINE-MODERNA-EPAR-PRODUCT-INFORMATION_BG.PDF) is SPIKEVAX.

1 . Name of medicinal product

SPIKEVAX injection dispersion Irna vaccine against COVID-19 (nucleoside modified)

2 . QUALITATIVE AND QUANTITATIVE COMPOSITION

This is a multidose vial that contains 10 doses of 0.5 ml. One dose (0.5 ml) contains 100 micrograms of information RNA (mRNA) (included in SM-102 lipid nanoparticles). Single-chain, 5'-CPN (mRNA) produced using a cell-free in vitro transcription from the respective DNA matrices encoding the SARS-COV-2 viral protein.

КРАТКАТА ХАРАКТЕРИСТИКА НА ПРОДУКТА МОЖЕТЕ ДА ПРОЧЕТЕТЕ И ТУК



Lastest news


Active campaigns

Система за ценообразуване и реимбурсиране на лекарствените продукти

Регистриран потребител в портала може да бъде всяко физическо или юридическо лице, което ще използва портала за подаване на електронни заявки за административни услуги. Процесът изисква наличие на квалифициран електронен подпис.

Code Health TV
CME Academy
Medicalnews
Cluster
Credoweb Learning Modul

International partners

IAMRA
WMA- World Medical Association
FEMS European Federation of Salaried Doctors
CPME The Standing Committee of European Doctors
UEMS European Union of Medical Specialists